360 High-Risk Vulnerability Immunization Tool V2.0 vs Wontok: Side-by-Side Comparison (2026)

Short answer

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats. Partners looking to monetize endpoint protection without building security from scratch should evaluate Wontok, which handles white-label deployment, user onboarding, and billing integration through modular APIs. The platform ranks competitively on AV-Comparatives anti-phishing benchmarks and covers device protection across consumer and enterprise use cases, with fully managed service options available. Skip this if you need deep endpoint detection and response; Wontok prioritizes ease of partner distribution and user engagement over threat hunting and forensic depth.

Based on our analysis of core features, company size fit, deployment model, here is our conclusion: